SCHEMBL2046482

SCHEMBL2046482

O=C(O)CCCCCC/C=C/C=C/CCCCCCCCC(=O)O

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FASN P49327 1/20 0.80
▸ PPARG P37231 4/20 0.65
▸ TERT O14746 3/20 0.65
▸ PTPN1 P18031 3/20 0.65
▸ PPARD Q03181 3/20 0.65
▸ PPARA Q07869 3/20 0.65
▸ MAPT P10636 3/20 0.65
▸ BLM P54132 2/20 0.65
▸ HSD17B10 Q99714 2/20 0.65
▸ FABP4 P15090 2/20 0.65
▸ F7 P08709 2/20 0.65
▸ F3 P13726 2/20 0.65
▸ LMNA P02545 2/20 0.65
▸ GMNN O75496 1/20 0.65
▸ USP2 O75604 1/20 0.65
▸ CYP1A2 P05177 1/20 0.65
▸ POLB P06746 1/20 0.65
▸ CYP2C9 P11712 1/20 0.65
▸ ALOX15 P16050 1/20 0.65
▸ APEX1 P27695 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28386319 1.00 FASN (0.80) FASNPPARGTERTPTPN1PPARD
SCHEMBL2046484 1.00 FASN (0.80) FASNPPARGTERTPTPN1PPARD
SCHEMBL3503263 0.91 FASN (0.69) FASNPPARGTERTPTPN1PPARD
SCHEMBL9444672 0.91 FASN (0.69) FASNPPARGTERTPTPN1PPARD
SCHEMBL2510598 0.91 FASN (0.69) FASNPPARGTERTPTPN1PPARD
SCHEMBL3176057 0.91 FASN (0.69) FASNPPARGTERTPTPN1PPARD
SCHEMBL9844676 0.91 FASN (0.69) FASNPPARGTERTPTPN1PPARD
SCHEMBL25293847 0.90 PPARG (0.78) PPARGTERTPTPN1PPARDPPARA
SCHEMBL320895 0.90 PPARG (0.78) PPARGTERTPTPN1PPARDPPARA
SCHEMBL16965368 0.90 PPARG (0.78) PPARGTERTPTPN1PPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3197936-B1 SILANE FUNCTIONALIZED COMPOUNDS AND COMPOSITIONS THEREOF WESTLAKE EPOXY INC (US) 2025-08-13 — — EP disclosed
CN-106715535-B Silane-functionalized compounds and compositions thereof 瀚森公司 2020-01-17 — — CN disclosed
US-10040896-B2 Silane functionalized compounds and compositions thereof Hexion, Inc. (US) 2018-08-07 — — US disclosed
EP-3197936-A1 SILANE FUNCTIONALIZED COMPOUNDS AND COMPOSITIONS THEREOF Hexion Research Belgium SA (BE) 2017-08-02 — — EP disclosed
US-20160090439-A1 SILANE FUNCTIONALIZED COMPOUNDS AND COMPOSITIONS THEREOF MOMENTIVE PERFORMANCE MATERIALS INC. 2016-03-31 — — US disclosed
WO-2016049192-A1 SILANE FUNCTIONALIZED COMPOUNDS AND COMPOSITIONS THEREOF HEXION INC. (US) 2016-03-31 — — WO disclosed
EP-2759579-A1 Protective Articles 3M Innovative Properties Company (US) 2014-07-30 — — EP disclosed
EP-1657287-B1 Protective articles 3M INNOVATIVE PROPERTIES CO (US) 2014-04-23 — — EP disclosed
US-20130224496-A1 High Hardness Low Surface Energy Coating HARDCOAT SURFACES LLC (US) 2013-08-29 — — US disclosed
EP-2510062-A2 PERFLUOROELASTOMER BONDING 3M Innovative Properties Company (US) 2012-10-17 — — EP disclosed
US-5308895-A A epoxy resin with a cure inhibitor, boric acid, catalyst and curing agents THE DOW CHEMICAL COMPANY (US) 1994-05-03 — — US disclosed
US-5183972-A Matching thermal coefficients of expansion of substrate and dielectric layer; high density, high performance circuits MICROELECTRONICS AND COMPUTER TECHNOLOGY CORPORATION (US) 1993-02-02 — — US disclosed
EP-0496163-A1 Stable amine advanced epoxy resin compositions THE DOW CHEMICAL COMPANY (US) 1992-07-29 — — EP disclosed
EP-0458502-A2 Latent catalysts, cure-inhibited epoxy resin compositions and laminates prepared therefrom THE DOW CHEMICAL COMPANY (US) 1991-11-27 — — EP disclosed
US-4882370-A Fiber reinforced composites with improved glass transition temperatures MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1989-11-21 — — US disclosed
EP-0326311-A1 Fiber reinforced composites with improved glass transition temperatures MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1989-08-02 — — EP disclosed
US-4461879-A FAST CURE TIME SHELL OIL COMPANY (US) 1984-07-24 — — US disclosed
US-4448847-A REMOVING OXIDE, PRETREATMENT WITH B-DIKETONE AND MERCAPTOESTER SHELL OIL COMPANY (US) 1984-05-15 — — US disclosed
US-4428987-A PRETREATMENT WITH SOLUTION OF A BENZOTHIAZOLE OR BENZOTRIAZOLE SHELL OIL COMPANY (US) 1984-01-31 — — US disclosed
EP-0077096-A2 Curable compositions and process for preparing a cured composition SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1983-04-20 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160090439-A1 SILANE FUNCTIONALIZED COMPOUNDS AND COMPOSITIONS THEREOF ILK, CAD, CAPG FASN 1214/4885PPARG 3421/4885TERT 1521/4885
US-10040896-B2 Silane functionalized compounds and compositions thereof ILK, CAD, CAPG FASN 1214/4885PPARG 3421/4885TERT 1521/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback